FDC
Back to Income Statement
|
FDC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹2,108 Cr | ₹1,943 Cr | ₹1,784 Cr | ₹1,528 Cr | ₹1,333 Cr |
What is the latest Revenue of FDC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹2,108 Cr |
| Mar2024 | ₹1,943 Cr |
| Mar2023 | ₹1,784 Cr |
| Mar2022 | ₹1,528 Cr |
| Mar2021 | ₹1,333 Cr |
How is Revenue of FDC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,108 Cr | 8.50 | |
| Mar2024 | ₹1,943 Cr | 8.92 | |
| Mar2023 | ₹1,784 Cr | 16.74 | |
| Mar2022 | ₹1,528 Cr | 14.61 | |
| Mar2021 | ₹1,333 Cr | - | |
Compare Revenue of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹7,006.9 Cr | 4.8% | 8.5% | -11.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,792.0 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FDC | 4.8% |
8.5% |
-11.3% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses